Report me for selling fake medicine? Why are you crying when your illness relapses?

However, this is not because they are worried about becoming the public enemy of global pharmaceutical companies, but simply because they want to make more money.

The reason why he sells it at a low price in the country is because of various benefits, so he can make a profit instead of losing money.

But what are sold at low prices abroad?

There is a fart.

"The factory price before tax is temporarily set at 5000 per box."

"Appropriate adjustments will be made based on the exchange rates and circumstances of each country, but the overall difference cannot be too large."

"As for how much tariffs each country has to pay, that's their business. Anyway, our ex-factory price doesn't include tax, so they just add whatever tariffs they want on top of the ex-factory price."

Chen Xuan looked out the window and said leisurely, "As for the agency rights, we can consider giving it to Novartis, but we must agree with Novartis that the price cannot be raised too much. It would be best if we can achieve a 10% profit."

In order to suppress the development of Chinese pharmaceutical companies, it also kills the market competitiveness of Chinese drugs.

Many countries will certainly impose additional tariffs, and this trick of theirs has long been common.

For some goods, they can add tariffs of 100%, or even more, and there is no guarantee that they will do so even for life-saving drugs.

These countries will not consider whether this is a life-saving drug, but only whether this life-saving drug will bring a huge market to China.

If so, that would be enough for them to find ways to suppress this life-saving drug.

As for whether this life-saving drug, Zhan Shang Tian, ​​will affect many people in their country, this is not a problem they are considering. Suppressing China and stifling the development of Chinese enterprises is the top priority.

Anyway, these countries don’t care, so it is even less likely that Chen Xuan will care about them.

Therefore, no matter how much tariffs these countries add, they will be added directly to the ex-factory price. No matter how much tariffs are added, the ex-factory price will be increased by that amount.

In short, the ex-factory price does not include tax, and the price is increased according to the tax rates of each country. Anyway, no matter how much the price increases, the medicine still has to be sold and it will not have any impact.

If these countries continue to impose tariffs, it will only make the local people more and more resentful of these countries.

Of course, this point needs to be publicized well. The key point is to let everyone in the world know about this tariff so that they can know the main contradiction.

Because of this, Chen Xuan simply handed over the agency rights for overseas markets to other pharmaceutical companies.

In this way, these pharmaceutical companies will also be responsible for resolving the crisis, and there is no need to worry about the conflict spreading to Antai Pharmaceutical Group, thus saving unnecessary trouble.

Anyway, Antai Pharmaceutical Group does not have sales channels in these overseas markets, and directly entrusting local pharmaceutical companies will be more conducive to the rapid distribution of new drugs.

Before you have your own advantages, there is no need to take on everything, and appropriate cooperation is also necessary.

There is no advantage in keeping the overseas agency rights in one's own hands, but if one exchanges them, one can indeed gain an ally.

Chen Xuan was very happy with this kind of deal.

As for choosing Novartis, the reason is very simple, mainly because the two companies have cooperated in the past.

Moreover, the previous cooperation was very harmonious and nothing unpleasant happened.

"Okay, Anna has contacted us too."

"She also very much hopes to cooperate with us. Their sales channels are very complete."

"Moreover, Novartis doesn't compete with us in this area, so they should be more motivated to promote our drugs. It's worth collaborating with them."

Luo Shiyun also made an assessment.

She also favors collaborating with Novartis.

There is certainly more than one international pharmaceutical giant, Novartis.

But other pharmaceutical giants are more or less competing with Antai Pharmaceutical Group, or they have not shown enough sincerity.

In comparison, Novartis is indeed the most suitable partner at the moment.

At the same time, they also showed their utmost sincerity. Anna's repeated contacts were the best proof.